Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

被引：0
|
作者：
Agersborg, Sally [1 ]
Mixon, Christopher [1 ]
Thanh Nguyen [1 ]
Aithal, Sramila [2 ]
Blocker, Forrest [1 ]
Weiss, Lawrence [1 ]
Gasparini, Robert [1 ]
Jiang, Shiping [1 ]
Chen, Wayne [1 ]
Hess, Gregory [3 ]
Albitar, Maher [1 ]
机构：
[1] NeoGenomics Inc, Aliso Viejo, CA USA
[2] Canc Treatment Ctr Amer, Philadelphia, PA USA
[3] Symphony Hlth, Conshohocken, PA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4524
引用
收藏
页数：2
相关论文
共 50 条
  • [41] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    Cancer Cell International, 22
  • [42] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [43] Resolution of Equivocal HER2 FISH: Reflex FISH or PCR?
    Damjanovich-Comenares, K.
    Willmore-Payne, C.
    Wilfahrt, P.
    Downs-Kelly, E.
    Geiersbach, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 814 - 814
  • [44] Comparison of fluorescence in situ hybridization (FISH) with immunohistochemistry (IHC) for detection of HER2/neu amplification/overexpression in breast cancer.
    Sun, G
    Morales, JS
    Wilz, S
    McKee, C
    Amberson, J
    Gersen, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 107 - 107
  • [45] Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer
    Xu, Bin
    Shen, Jianguo
    Guo, Wenhao
    Zhao, Wenhe
    Zhuang, Yiyu
    Wang, Linbo
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 251 - 255
  • [46] Impact of the 2013 ASCO/CAP Guideline Recommendations for HER2Testing of Invasive Breast Carcinoma: A Focus on Tumors Assessed as Equivocal for HER2 Gene Amplification By FISH
    Bethune, Gillian
    van Zanten, Daniel Veldheijzen
    Younis, Tallal
    Rayson, Daniel
    Thompson, Kara
    Barnes, Penny
    LABORATORY INVESTIGATION, 2015, 95 : 35A - 35A
  • [47] HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+Breast Cancer With Early Recurrence
    Yamashita, Hiroko
    Ishida, Naoko
    Hatanaka, Yutaka
    Hagio, Kanako
    Oshino, Tomohiro
    Takeshita, Takashi
    Kanno-Okada, Hiromi
    Shimizu, Ai
    Hatanaka, Kanako C.
    Matsuno, Yoshihiro
    ANTICANCER RESEARCH, 2020, 40 (02) : 645 - 652
  • [48] Equivocal (2+) HER-2/neu results by immunohistochemistry in breast carcinoma: "normalizing" reduces need for FISH testing
    Santiano, Estrella J.
    Salvatore, P. S.
    Hoda, A. S.
    VIRCHOWS ARCHIV, 2009, 455 : 192 - 192
  • [49] Equivocal HER-2/NEU Expression of Breast Carcinoma by Immunohistochemistry: Comparing the Rate of FISH Amplification Between Two Laboratories
    Sathiyamoorthy, Srividya
    Sidawy, Mary
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A197 - A197
  • [50] The Effect of HER2 Amplification in HER2+Breast Cancer
    Lee, M. K.
    Hurvitz, S. A.
    Tran, B. N.
    Fu, Y.
    Chung, D. U.
    Gornbein, J.
    Apple, S. K.
    Chang, H. R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S45 - S45
12345